Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to determine if intervening with combined local therapy and chemotherapy prior to chemotherapy alone in patients with oligorecurrent and oligometastatic esophageal squamous cell carcinoma led to significant improvements in progression-free survival (PFS).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03904927
Study type Interventional
Source Fudan University
Contact
Status Active, not recruiting
Phase Phase 2
Start date February 1, 2019
Completion date September 15, 2024